Cannabis News

MJardin Group, Inc. (" MJardin " or the " Company ") (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced that it has reached an agreement with Harvest Health & Recreation Inc. (" Harvest ") (CSE: HARV, OTCQX:HRVSF) for final settlement and reduction of the previously disclosed final payment relating to the December 2019 sale of MJardin's Cheyenne facility to Harvest (the " Transaction ") for the amount of US$4.25 million.

In accordance with the requirements of the Company's existing credit facility, the Company shall cause certain of its subsidiaries to use the Canadian dollar equivalent of this final US$4.25 million payment to repay a portion of the accrued interest owing from such subsidiaries to the Company's senior lender. In connection with this debt repayment, the senior lender has agreed to the establishment of a new revolving credit facility in favour of such subsidiaries of the Company in an aggregate maximum principal amount of C$5,326,525 (the " Maximum Amount ").   This facility is established as a sub-facility under the existing credit facility between the senior lender and such subsidiaries of the Company and will bear interest at a rate of 15% per annum, compounded monthly, with a one-time work fee of 2% of the Maximum Amount paid to the senior lender.

The Company also announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2020, before market open on April 30, 2021.

About MJardin Group

MJardin Groups' mission is to set the standard for successful ownership of assets in the cannabis industry. Our founders spent a decade refining cultivation methodology, collecting and implementing data driven standards and designing state of the art facilities. Today, MJardin Group owns multiple operations in Canada, supplying the market with premium products. We are committed to our Canadian First Nation joint ventures and all our strategic partnerships across the cannabis supply chain. MJardin Group is publicly listed on the CSE (MJAR) and headquartered in Toronto, Ontario and Denver, Colorado.

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933 , as amended (the " U.S. Securities Act ") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995 . Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may', ‘will', ‘should', ‘could', ‘would', ‘expects', ‘intends', ‘plans', ‘anticipates', ‘believes', ‘estimates', ‘projects', ‘predicts', ‘potential', ‘outlook' or ‘continue' or the negative of those forms or other comparable terms. Statements about, among other things, future developments in the business and operations of MJardin Group, the approval by the Nevada regulatory authorities of the license transfer to Harvest with respect to the Cheyenne facility, the use of proceeds from the Transaction, and statements regarding the potential, timing, and examples of any strategic alternatives, contain forward-looking information. These statements should not be read as guarantees of future performance or results. The Company's forward-looking information and forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information and forward-looking statements, including but not limited to: our ability to identify and pursue growth, financing and other strategic objectives, and the regulatory and economic environments in the jurisdictions we operate or intend to operate or invest in. Reference should also be made to the risks and uncertainties which are discussed in greater detail in the "Risk Factors" section of the Company's Annual Management's Discussion and Analysis filed on SEDAR and as described from time to time in documents filed by the Company with Canadian securities regulatory authorities. Readers are cautioned that the foregoing list of factors is not exhaustive. Although such statements are based on management's reasonable assumptions at the date such statements are made, there can be no assurance that any proposed transactions will occur or that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information and forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking information and forward-looking statements. No assurances are given as to the future trading price or trading volumes of MJardin Group's shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking information and forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. MJardin Group assumes no responsibility to update or revise forward-looking information and forward-looking statements to reflect new events or circumstances unless required by applicable law.

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company's operations and financial performance.

Investor Contact

Ali Mahdavi
Capital Markets & Investor Relations
ali.mahdavi@mjardin.com
+1.416.962.3300

Pat Witcher
Chief Executive Officer
pat.witcher@mjardin.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

pair of hands holding cannabis buds

Lift Expo Show Floor Marked by Calls for Cannabis Action and Unity

The most recent edition of the Lift & Co. Expo, held this past weekend in Toronto, brought multiple calls to action among cannabis industry stakeholders.

In panels at the show and in conversations with the Investing News Network (INN), experts used this year’s event to urge all types of cannabis companies to collaborate in high-level lobbying.

During the event, a distinct theme appeared: the need for firms in the cannabis market to better advocate for themselves in front of the Canadian government.

Keep reading...Show less

Trulieve Celebrates Two Medical Dispensary Openings in West Virginia

South Charleston and Parkersburg locations both opening on Saturday, May 21 at 10 a.m.

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of its third and fourth medical dispensaries in West Virginia . Located at 4701 MacCorkle Ave. SW in South Charleston and 152 Park Shopping Center in Parkersburg both dispensaries will open at 10 a.m. on Saturday, May 21, 2022 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

American Green, Inc. Purchases 40,000 square foot Cannabis Grow Building for $3,750,000

The building appraised for $5,300,000 and gives American Green total equity of $2,673,000; over 50% of the property value


May 18, 2022 - American Green, Inc. (ERBB:OTC) has purchased the 40,000 square foot building known as American Green's "Cypress Chill" cannabis facility located at 2325 W. Cypress St. Phoenix, AZ. 85009.  The building sits on a 62,000 square foot site and was previously leased by ERBB in August 2021 with an option to buy. American Green has exercised its option to buy the building and now owns it. The purchase price was set at $3.75 million at the time of the signing of the lease last year. Recently, the building was professionally appraised for $5.3 million, giving American Green $1.55 million of additional equity, at the time of closing. When added to the down payment of $1.123 million, there is now a total of $2.673 million of equity in the new "Cypress Chill" cannabis grow building.

News Provided by NewMediaWire via QuoteMedia

Keep reading...Show less

Canopy Growth Announces Plan to Acquire Jetty Extracts

Broadens Canopy Growth's Portfolio of Premium Brands with Significant Opportunities to Scale Across North America

Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC) and Lemurian, Inc. ("Jetty"), a California -based producer of high-quality cannabis extracts and pioneer of clean vape technology, announced today that they have entered into definitive agreements (the "Agreements") providing Canopy Growth, by way of a wholly-owned subsidiary ("Canopy Sub"), the right to acquire, upon federal permissibility of THC in the U.S. or earlier at Canopy Growth's election, up to 100% of the outstanding capital stock of Jetty.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
AgriFORCE Growing Systems Completes Acquisition of Food Production & Processing IP from Manna Nutritional Group

AgriFORCE Growing Systems Completes Acquisition of Food Production & Processing IP from Manna Nutritional Group

AGRIFORCE Growing Systems Ltd. ("the Company") (NASDAQ: AGRI; AGRIW) an intellectual property (IP)-focused AgTech company dedicated to advancing sustainable cultivation and crop processing across multiple verticals, today announced it has completed the previously announced acquisition of the intellectual property of Manna Nutritional Group (MNG). The IP encompasses patent-pending technologies to naturally process and convert grain, pulses and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour products, as well as a wide range of breakfast cereals, juices, natural sweeteners and baking enhancers. The core process is covered under a pending patent application in the U.S. and key international markets.

Independent lab testing indicates that MNG's soft white wheat baking flour contains over 30 times the fiber, 3 times the protein, and more than 80% less starch than conventional flour without compromising taste, texture and quality [1] . The Company's initial focus is on wheat, in which the flour has applications for baked goods, breads and snacks.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility

State-of-the-art facility readying first delivery of medical grade cannabis for German patients

Aurora Cannabis Inc. (the " Company " or " Aurora ") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the company has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany . As a leading manufacturer of medical cannabis worldwide, achieving EU-GMP certification of the company's first German manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the German Federal Institute for Drugs and Medical Devices (BfArM). Aurora is the distinct market leader in the German flower segment and will now leverage receiving the world's highest quality standard to produce and distribute premium medical cannabis in Germany .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×